Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.935
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
4f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.306
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
1f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.544
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0413
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
6f:m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.117
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
1f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0811
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
6f:m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.155
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Simplified IPGTT / Blood glucose concentration
|
HOM
|
40f:40m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
1f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.307
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
4f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.745
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
1f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.159
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
6f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.308
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
6f:m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.266
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
1f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.760
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Urinalysis / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0775
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.139
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.225
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.234
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0296
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00712
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.605
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Iron
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.186
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.342
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total protein
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000943
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.419
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Albumin
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00104
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0334
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Urinalysis / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
5.53×10-11
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0887
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.114
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.291
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
DEXA / Fat/Body weight
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.821
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0572
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
DEXA / Fat mass
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.526
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.379
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Calorimetry / Carbon dioxide production
|
HOM
|
640f:434m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0263
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Calorimetry / Oxygen consumption
|
HOM
|
640f:434m
|
|
|
NotProcessed |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Calcium
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0868
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Urinalysis / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00527
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Glucose
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0751
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Dysmorphology / fat distribution
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Sodium
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0321
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0848
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Urinalysis / microAlbumin (calculated)
|
HOM
|
7f:2m
|
Linear Mixed Model framework, LME, including Weight
|
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.258
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Potassium
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.908
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Phosphorus
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.219
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0616
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.518
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0172
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.611
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.739
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Chloride
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.919
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
40f:40m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.130
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.832
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
7f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0507
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.669
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.729
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00394
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.930
|
Successful |
Tpcn1Gt(XG716)Byg
|
MRC Harwell
|
Simplified IPGTT / Glucose response AUC
|
HOM
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.546
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Triglycerides
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.000290
|
Successful |
Tpcn1tm1.1(KOMP)Vlcg
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.00183
|
Successful |